Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Lechuang Chen and Ge Jin*
Kaposi sarcoma herpesvirus (KSHV; also known as Human Herpes Virus 8 (HHV8)) is a causal agent for
Kaposi’s Sarcoma (KS), a leading cause of mortality and morbidity in people living with HIV/AIDS. In most of
sub-Saharan Africa, the seroprevalence of KSHV infection reaches over 50%. In the United States and Europe, the
prevalence of KSHV is less than 10% in the general population. Although KSHV infection is a key factor for KS to
develop, in most cases infection with KSHV alone does not lead to KS. Globally, KS incidence is around 1 in 100,000 in
the general population compared to 1 in 20 in HIV-infected individuals. That means HIV infection is the most important
cofactor of the KSHV infection. Despite advances in our understanding of virology and pathogenesis of KSHV in recent
years, but how HIV infection strengthens does the infection and transmission of KSHV are still not well understood.